Cargando…

Characterizing the degradation of cannabidiol in an e-liquid formulation

The reported characteristics of cannabidiol (CBD) have encouraged significant growth in commercial CBD products. There is limited information on the stability of CBD and some researchers have noted significant reductions of CBD in products. In this study, the chemical profiles of plant-based and che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarzenberg, Adrián, Carpenter, Harry, Wright, Christopher, Bayazeid, Omer, Brokl, Michał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681878/ https://www.ncbi.nlm.nih.gov/pubmed/36414659 http://dx.doi.org/10.1038/s41598-022-23910-6

Ejemplares similares

Rapid determination of levels of the main constituents in e-liquids by near infrared spectroscopy
por: Hoffmann, Anaïs R. F., et al.
Publicado: (2023)

Formulation of Cannabidiol in Colloidal Lipid Carriers
por: Francke, Nadine Monika, et al.
Publicado: (2021)

Quantification of the content of cannabidiol in commercially available e-liquids and studies on their thermal and photo-stability
por: Mazzetti, Carlo, et al.
Publicado: (2020)

Formulation of Nanomicelles Loaded with Cannabidiol as a Platform for Neuroprotective Therapy
por: Yordanov, Yordan, et al.
Publicado: (2022)

Phenylethanoid glycosides as a possible COVID-19 protease inhibitor: a virtual screening approach
por: Bernardi, Mario, et al.
Publicado: (2021)

Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes
por: Peace, Michelle R., et al.
Publicado: (2016)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L.
por: Martinenghi, Laura Daniela, et al.
Publicado: (2020)

Author Correction: Quantification of the content of cannabidiol in commercially available e-liquids and studies on their thermal and photo-stability
por: Mazzetti, Carlo, et al.
Publicado: (2021)

Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
por: Merrick, John, et al.
Publicado: (2016)

Improvement of Ylang-Ylang Essential Oil Characterization by GC×GC-TOFMS
por: Brokl, Michał, et al.
Publicado: (2013)

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
por: Abbotts, Kieran Shay Struebin, et al.
Publicado: (2022)

Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique
por: Limpongsa, Ekapol, et al.
Publicado: (2022)

The roles of valerenic acid on BDNF expression in the SH-SY5Y cell
por: Gonulalan, Ekrem-Murat, et al.
Publicado: (2018)

Depth-selective fiber-optic probe for characterization of superficial tissue at a constant physical depth
por: Fang, Can, et al.
Publicado: (2011)

Cyclodextrin inclusion complex inhibits circulating galectin-3 and FGF-7 and affects the reproductive integrity and mobility of Caco-2 cells
por: Maki, Marwan Abdelmahmoud Abdelkarim, et al.
Publicado: (2020)

A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
por: Johnson, Drusus A., et al.
Publicado: (2023)

Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Cannabidiol Reduces Leukemic Cell Size – But Is It Important?
por: Kalenderoglou, Nikoletta, et al.
Publicado: (2017)

Simultaneous untargeted and targeted metabolomics profiling of underivatized primary metabolites in sulfur-deficient barley by ultra-high performance liquid chromatography-quadrupole/time-of-flight mass spectrometry
por: Ghosson, Hikmat, et al.
Publicado: (2018)

Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy
por: Santos, Susana, et al.
Publicado: (2022)

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
por: Malaca, Sara, et al.
Publicado: (2021)

In situ Gelling Hydroxypropyl Cellulose Formulation Comprising Cannabidiol-Loaded Block Copolymer Micelles for Sustained Drug Delivery
por: Kamenova, Katya, et al.
Publicado: (2023)

LIQUID FORMULATION OF MINOXIDIL VERSUS ITS FOAM FORMULATION
por: Purnak, Tugrul, et al.
Publicado: (2011)

Formulation, Preparation, Characterization, and Evaluation of Dicarboxylic Ionic Liquid Donepezil Transdermal Patches
por: Dinh, Linh, et al.
Publicado: (2022)

In Vitro Release, Mucosal Permeation and Deposition of Cannabidiol from Liquisolid Systems: The Influence of Liquid Vehicles
por: Tabboon, Peera, et al.
Publicado: (2022)

A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
por: Giacoppo, Sabrina, et al.
Publicado: (2015)

Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
por: Crippa, José A., et al.
Publicado: (2021)

Correction: Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

The antimicrobial potential of cannabidiol
por: Blaskovich, Mark A. T., et al.
Publicado: (2021)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

Development, Characterization and Pharmacological Evaluation of Cannabidiol-Loaded Long Circulating Niosomes
por: Gugleva, Viliana, et al.
Publicado: (2023)

On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva
por: Franco, Valentina, et al.
Publicado: (2022)

In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229
por: Chatow, Lior, et al.
Publicado: (2021)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Extemporaneously compounded liquid formulations of clofazimine
por: Taneja, R., et al.
Publicado: (2023)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
por: Kitamura, Masashi, et al.
Publicado: (2020)

Cannabidiol as a Modulator of the Development of Alcohol Tolerance in Rats
por: Szulc, Michał, et al.
Publicado: (2023)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
por: Meyer, Kelsey, et al.
Publicado: (2022)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
por: Fortin, Davide, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_srcg5f4io3e2k8vfo7rme5hkqe